Atlas Trials

Oral Resveratrol to Prevent Post-ERCP Pancreatitis

Clinical trial NCT02947932 · UNKNOWN

Trial details

NCT number
NCT02947932
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Pancreatitis, AcuteGastrointestinal Disease
Start date
2016-12-01
Primary completion
2018-03-01
Enrollment
2700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.